As smoking rates fall in the U.S., startups and influencers are pushing the purported cognitive and health benefits of ...

A handful of states are considering initiatives to increase funding for scientific research as uncertainty around federal ...

We do not let pilots fly without instrument support simply because they technically could. Why should medicine be different?” ...

The FDA's top drug regulator indicated in her first address to staff that she will scrutinize antidepressants and shots used to protect babies from RSV ...

And there’s more news out of the FDA: The agency has installed an AI industry vet to steer digital health, and new CDER chief Tracy Beth Høeg tells staff she’s keen to revisit SSRIs in pregnancy and ...

Would you trust AI to renew your drug prescriptions? Alex Hogan explores the question on this week's episode of STATus Report.

Joe Sachs, a physician and executive producer on “The Pitt,” and the CEO of Undue Medical Debt weigh in on the show’s foray into a health care crisis.

Grail's blood test for detecting cancer early failed to meet its main goal in a giant study being conducted with England’s ...

Federal officials have missed the legal deadline to notify the public of an upcoming ACIP meeting, raising questions about ...

Hims & Hers is buying the Australian telehealth firm Eucalyptus as it looks to make inroads in more countries globally.

Gossamer Bio will be reporting the outcome of a late-stage study in pulmonary arterial hypertension. Here's what to know.

The top drug regulator at the FDA told staff she plans to question the safety of taking SSRIs in pregnancy and of RSV shots ...